Connor Clark & Lunn Investment Management Ltd. Cuts Stock Position in Utah Medical Products, Inc. (NASDAQ:UTMD)

Connor Clark & Lunn Investment Management Ltd. lowered its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 55.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,603 shares of the medical instruments supplier's stock after selling 5,734 shares during the period. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.14% of Utah Medical Products worth $283,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. Martingale Asset Management L P raised its stake in shares of Utah Medical Products by 5.3% in the third quarter. Martingale Asset Management L P now owns 3,968 shares of the medical instruments supplier's stock worth $266,000 after purchasing an additional 201 shares during the last quarter. Bard Associates Inc. boosted its holdings in shares of Utah Medical Products by 1.3% during the 4th quarter. Bard Associates Inc. now owns 20,030 shares of the medical instruments supplier's stock valued at $1,237,000 after acquiring an additional 249 shares during the last quarter. Golden State Wealth Management LLC bought a new stake in shares of Utah Medical Products in the fourth quarter worth approximately $31,000. BNP Paribas Financial Markets raised its holdings in shares of Utah Medical Products by 102.7% during the third quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier's stock valued at $75,000 after purchasing an additional 566 shares during the last quarter. Finally, State Street Corp boosted its holdings in Utah Medical Products by 0.9% in the third quarter. State Street Corp now owns 80,856 shares of the medical instruments supplier's stock worth $5,434,000 after purchasing an additional 694 shares during the last quarter. 69.60% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Utah Medical Products Price Performance

Shares of UTMD remained flat at $56.72 during trading hours on Thursday. The company had a trading volume of 13,747 shares, compared to its average volume of 20,519. The company has a market cap of $192.39 million, a price-to-earnings ratio of 14.36 and a beta of 0.06. Utah Medical Products, Inc. has a one year low of $56.46 and a one year high of $77.33. The firm has a 50 day moving average price of $59.95 and a two-hundred day moving average price of $62.97.

Utah Medical Products (NASDAQ:UTMD - Get Free Report) last released its quarterly earnings results on Tuesday, January 28th. The medical instruments supplier reported $0.86 earnings per share (EPS) for the quarter. Utah Medical Products had a return on equity of 11.07% and a net margin of 33.92%.

Utah Medical Products Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, April 3rd. Investors of record on Friday, March 14th will be issued a $0.305 dividend. This represents a $1.22 annualized dividend and a yield of 2.15%. The ex-dividend date of this dividend is Friday, March 14th. Utah Medical Products's dividend payout ratio is 30.89%.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.